This followed the active pharmaceutical ingredient (API) manufacturer's strong earnings print in Q4FY24.
The pharma firm's stock ended the day with gains of 3.2 per cent at ₹4,222 a share.
While analysts said they were positive about the firm's performance and its FY25 commentary, they said the stock price might see some downsides amid rich valuation.
The March quarter of FY24 saw the company's net profit rise 67 per cent to ₹538 crore compared to ₹321 crore in the corresponding period last year. Its revenue grew 18 per cent to 2,303 crore.
Esta historia es de la edición May 28, 2024 de Business Standard.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor ? Conectar
Esta historia es de la edición May 28, 2024 de Business Standard.
Comience su prueba gratuita de Magzter GOLD de 7 días para acceder a miles de historias premium seleccionadas y a más de 9,000 revistas y periódicos.
Ya eres suscriptor? Conectar
India, US extend 2% digital tax pact on e-commerce
India and the United States have decided to extend the agreement relating to 2 per cent equalisation levy, or digital tax, imposed by New Delhi on e-commerce platforms till June 30, the finance ministry said on Friday.
Brokerages turn bullish on telcos after tariff hike
Bharti Artel and Reliance Jio (RJio) announced a hike in tariffs across telecom plans with effect from July 3.
Emcure Pharma looks to raise ₹1,952 cr via IPO
Emcure Pharmaceuticals has set a price band of ₹960-1,008 per share for its initial public offering (IPO) that opens for subscription on July 3.
ICICI Prudential MF launches energy fund with eye on demand growth
ICICI Prudential Mutual Fund (MF) has announced the launch of Energy Opportunities Fund, a thematic scheme which will look to ride the energy growth demand wave and capture the emerging opportunities in the renewables space.
Geopolitics biggest risk to markets: Chris Wood
Geopolitics, particularly, the growing risk of escalation in the Russia-Ukraine conflict, remains by far the biggest risk the markets, wrote Christopher Wood (pictured), global head of equity strategy at Jefferies in his weekly note to investors, GREED & fear.
Indices snap winning streak
Equity benchmark Sensex on Friday fell for the first time in seven days, while the Nifty 50 index notched up its first loss in five days.
Navigating the hype-reality divide
It has been an education watching the T20 World Cup and the Euro on my mobile.
Attracting Netravalkars
EYE CULTURE VISHAL MENON The average Indian male loathes Saurabh Netravalkar.
A new paradigm for creating jobs
It would be prudent to take up a few sectors initially, get the policy instruments right, and put in the critical mass of resources to achieve a self-sustaining inflection point
Three elections, three mistakes
Joe Biden had a disastrous evening on the debate stage on Thursday.
